Carcinoembryonic Antigen (CEA) Scan in the Diagnosis of Recurrent Colorectal Carcinoma in a Patient with Increasing CEA Levels and Inconclusive Computed Tomographic Findings

Clinical Nuclear Medicine

Volumn 28, Issue 7, 2003, Pages 608-609

  Ghesani, Munir ^a,b   Belgraier, Arnold ^b   Hasni, Sofia ^b  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Carcinoembryonic antigen; Colorectal carcinoma; Computed tomography

Indexed keywords

CARCINOEMBRYONIC ANTIBODY; CARCINOEMBRYONIC ANTIGEN; TECHNETIUM 99M; DIAGNOSTIC AGENT; MONOCLONAL ANTIBODY; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M ARCITUMOMAB;

ARTICLE; BLADDER CATHETERIZATION; CASE REPORT; COLORECTAL CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; FOLLOW UP; GAMMA SCINTIGRAPHY; HEMATURIA; HUMAN; INVASIVE CARCINOMA; PELVIS; RADIOISOTOPE DISTRIBUTION; RECURRENT CANCER; SCAR FORMATION; SIGMOIDECTOMY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR DIFFERENTIATION; ADENOCARCINOMA; BLOOD; COLORECTAL TUMOR; PATHOLOGY; RADIOGRAPHY; SCINTISCANNING; TUMOR RECURRENCE;

ADENOCARCINOMA; ANTIBODIES, MONOCLONAL; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; HUMANS; NEOPLASM RECURRENCE, LOCAL; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS;

EID: 85047693698     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200307000-00021     Document Type: Article

References (8)

1. Biggs CG, Ballantyne GH: Sensitivity versus cost effectiveness in postoperative follow-up for colorectal cancer. Curr Opin Gen Surg 94:102, 1994.
2. Freeny PC, Marks WM, Ryan JA, et al: Colorectal carcinoma evaluation with CT: preoperative staging and detection of postoperative recurrence. Radiology 158:347, 1986.
3. Collier BD, Abdel-Nabi H, Doerr RJ, et al: Immunoscintigraphy performed with In 111-labeled CYT-103 in the management of colorectal cancer: comparison with CT. Radiology 185:179, 1992.
4. Charnsangavej C: New imaging modalities for follow-up of colorectal carcinoma. Cancer 71:4236, 1993.
5. Steele G Jr, Bleday R, Mayer RJ, et al: A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584. J Clin Oncol 9:1105, 1991.
6. Moffat FL, Pinsky CM, Hammershaimb L, et al: The Immunomedics Study Group. Clinical utility of external immunoscintigraphy with the IMMU-4 Tc-99m-Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum. Results of a pivotal phase III trial. J Clin Oncol 14:2295, 1996.
7. Libutti SK, Alexander HR Jr, Choyke P, et al: A prospective study of 2-[18F] fluoro-2-deoxy-D-glucose/positron emission tomography scan, 99mTc-labeled arcitumomab (CEA-scan), and blind second-look laparotomy for detecting colon cancer recurrence in patients with increasing carcinoembryonic antigen levels. Ann Surg Oncol 8:779, 2001.
8. Lechner P, Lind P, Goldenberg DM: Can postoperative surveillance with serial CEA immunoscintigraphy detect resectable rectal cancer recurrence and potentially improve tumor-free survival? J Am Coll Surg 191:511, 2000.